Antiherpes drugs: promises and pitfalls. - Wikidata - wikimedia - TriplyDB

Antiherpes drugs: promises and pitfalls.

Antiherpes drugs: promises and pitfalls.

http://www.wikidata.org/entity/Q40142222

about

Recent advances in antiherpetic drugs.5'-O-D-valyl ara A, a potential prodrug for improving oral bioavailability of the antiviral agent vidarabine.Murine mammary FM3A carcinoma cells transformed with the herpes simplex virus type 1 thymidine kinase gene are highly sensitive to the growth-inhibitory properties of (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.

P2860

Q39318970-8565C602-17C7-4E39-9B55-ED987D654AB8 Q39899952-A895EB35-2F1A-49B1-9F1B-F332B1B7BF29 Q45838762-F232E4AE-AA7F-47BE-9962-99A5E35D8EF0

P2860

Antiherpes drugs: promises and pitfalls.

http://www.wikidata.org/entity/Q40142222

description

1984 nî lūn-bûn

@nan

1984年の論文

@ja

1984年論文

@yue

1984年論文

@zh-hant

1984年論文

@zh-hk

1984年論文

@zh-mo

1984年論文

@zh-tw

1984年论文

@wuu

1984年论文

@zh

1984年论文

@zh-cn

name

Antiherpes drugs: promises and pitfalls.

@en

type

label

Antiherpes drugs: promises and pitfalls.

@en

prefLabel

Antiherpes drugs: promises and pitfalls.

@en

P1433

Q40142222-DA9CAB59-97FB-4FDD-8F53-25D20AC3C6D0

P1476

Q40142222-EC842D24-B344-4FF3-A896-3F18F37C7B4C

P2093

Q40142222-90C45D76-826F-4FF9-893D-F101CADB006D

P2860

Q40142222-17B3D66F-88F0-4941-95B5-DA2409E015F2

Q40142222-1B34D5F6-72A4-4DBA-A1B0-C0AC211C6D04

Q40142222-21CBA1D6-61A3-4514-9AF1-232207460187

Q40142222-236D2EC7-0777-4D50-98E2-BDD6A4BB4BAD

Q40142222-2F4E2F91-33B5-494F-B3E1-D7353DFC6BF5

Q40142222-31FE51EA-9F44-4C14-979D-FABD624425B1

Q40142222-3F04D50F-45E0-401B-8B85-BEB58BD1C460

Q40142222-43EA96D4-1324-47AF-843A-3349933D0EAA

Q40142222-4AC4D562-DC5F-4B21-BCEA-6EC457161DF8

Q40142222-589EFACB-9B00-424A-AAC1-5E51156003CA

P304

Q40142222-86915EA8-5822-4C3C-842B-394AD1D80A4F

P31

Q40142222-33534A09-004E-45C8-A4EA-2B54D9F8461C

P356

Q40142222-A7068AA9-58F8-48A4-89F3-516B897533D8

P433

Q40142222-36302971-223E-4B91-B369-B6F6E1865451

P478

Q40142222-50D0FE1A-9CBC-451E-8B82-FAE18F59940C

P577

Q40142222-68110BBF-3584-485E-81FB-BC3F78CB331A

P698

Q40142222-ACC0CB3E-CC6E-4D61-A0B5-DB4CD7AE370D

P356

P1433

European journal of clinical microbiology

P1476

Antiherpes drugs: promises and pitfalls.

@en

P2093

E de Clercq

http://www.w3.org/2001/XMLSchema#string

P2860

Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo

In vitro susceptibility of varicella-zoster virus to acyclovir

Effect of acyclovir on latent herpes simplex virus infections in trigeminal ganglia of mice

In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compounds

Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine

Synergistic antiviral activity of acyclovir and interferon on human cytomegalovirus

Efficacy and selectivity of some nucleoside analogs as anti-human cytomegalovirus agents

Therapeutic activities of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine and -thymine alone and in combination with acyclovir and vidarabine in mice infected intracerebrally with herpes simplex virus

Comparison of the efficacy of vidarabine, its carbocyclic analog (cyclaradine), and cyclaradine-5'-methoxyacetate in the treatment of herpes simplex virus type 1 encephalitis in mice

Ineffectiveness of adenine arabinoside and adenine arabinoside 5'-monophosphate in simian varicella infection

P304

96-107

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/BF02014325

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

1984-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

6327297

http://www.w3.org/2001/XMLSchema#string